"The decline in circulating tumor cells (“CTCs
Post# of 155600

& .....
"Confirming the full extent of leronlimab’s activity on the primary tumor is on our short list of clinical priorities in the coming months."
___
That....is why the recent filings
Just like I said on 7/27/2025:
https://investorshangout.com/post/view?id=6779023
There is no way we do not prove & get historically credited with the MOA that has changed humanity.

